HPV vaccine reduces cancer causing infection in England by 86 per cent

26 June 2018

Article: 52/2502

New surveillance data from England, published on 18 June 2018 in the Journal of Infectious Diseases, has found that the human papillomavirus (HPV) vaccination has led to significant reductions in the number of young women who have the infection. HPV16 and 18 infections, which cause most cervical cancer cases, decreased by 86% in women aged 16 to 21 who were eligible for the vaccination as adolescents between 2010 and 2016.

The results suggest that the HPV vaccination programme will bring about large reductions in cervical cancer in the future. In addition, the programme has led to a marked decline in genital wart diagnoses. Between 2009 and 2017 the number of genital wart diagnoses in sexual health clinics in England fell in girls aged 15 to 17 by 89% and in boys of the same age by 70%.

The HPV vaccination programme was first introduced in 2008. Over 80% of people aged 15 to 24 have now been vaccinated in the UK and 80 million have received the vaccine worldwide.

Source: PHE, 18 June 2018